|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$55,845.00 |
2.88% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$53,498.16 |
2.76% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$51,714.96 |
2.67% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$49,756.86 |
2.57% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$49,423.92 |
2.55% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$49,378.87 |
2.55% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$46,732.81 |
2.41% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$46,454.95 |
2.40% |
| Waters Corporation |
WAT |
941848103 |
123 |
$46,509.99 |
2.40% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$45,619.38 |
2.36% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$43,077.00 |
2.23% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$42,280.04 |
2.18% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$41,889.69 |
2.16% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$41,198.23 |
2.13% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$41,147.83 |
2.13% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$40,970.99 |
2.12% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$40,933.66 |
2.11% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$40,905.73 |
2.11% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$40,553.07 |
2.09% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$40,100.04 |
2.07% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$40,003.20 |
2.07% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$39,948.32 |
2.06% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$39,716.40 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$39,265.79 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$39,011.40 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$38,989.50 |
2.01% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$38,133.46 |
1.97% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,680.76 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,655.17 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
177 |
$37,577.10 |
1.94% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$36,353.24 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$36,134.56 |
1.87% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$35,719.20 |
1.85% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$35,519.74 |
1.83% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$35,007.06 |
1.81% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,894.68 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$34,842.14 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$34,589.20 |
1.79% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$34,066.00 |
1.76% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$33,867.82 |
1.75% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$33,728.59 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$33,489.98 |
1.73% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$33,042.60 |
1.71% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$32,169.60 |
1.66% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$31,958.00 |
1.65% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$30,914.21 |
1.60% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$29,674.66 |
1.53% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$27,429.22 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$26,374.13 |
1.36% |
| US Dollar |
$USD |
|
9,615 |
$9,615.12 |
0.50% |
| New Zealand Dollar |
$NZD |
|
679 |
$385.37 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|